Health
Altering balance of fibroblasts could prevent spread of colorectal cancer – Drug Target Review
Researchers found colorectal cancer-associated fibroblasts can be altered with a gremlin 1-neutralising antibody or overexpressing meflin.
Posted: 1 February 2021 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have found that colorectal cancer-associated fibroblasts can be altered using a gremlin 1-neutralising antibody or by overexpressing meflin.
Researchers have revealed that colorectal cancer tissues contain at least two types of fibroblasts – cancer-promoting fibroblasts and cancer-restraining fibroblasts. The team, from Nagoya University, Japan, found that the balance between the two is largely involved in…
-
General9 hours agoFerries and celebrities as pollies dash to win the west
-
Noosa News14 hours agoCSIRO, winemakers pair to breed mildew, climate-resistant grapevines
-
Noosa News18 hours agoSpinach salads back on supermarket shelves amid E. coli probe
-
Business19 hours ago$10,000 invested in Telstra shares at Christmas is now worth